NCT00853164

Brief Summary

60 eligible subjects will be randomized into one of three study arms 1) aerobic exercise, 2) resistance exercise, or 3) usual care. Baseline measurements will be done on all study subjects, these measurements include: height, weight, dual energy x-ray absorptiometry (DXA) for bone mineral density and lean body mass measurements, blood will be taken to measure serum free testosterone, prostate-specific antigen (PSA), glucose, and insulin levels. Fitness will also be evaluated using a graded exercise test. Questionnaires on health and personal history will also be completed. Men randomized to the aerobic exercise treatment arm will participate in a walking program three times a week for eight weeks. The participants will start at 15 minutes per session and increase to a goal of 60 minutes per session. Men randomized to the resistance training treatment arm will participate in an eight-week program of eight strength training exercises three times per week. Men in the usual care arm will receive written materials from the American Cancer Society about coping with cancer, which includes information about participation in physical activity. At the end of the eight week intervention participants in all three study arms will complete the same questionnaires and measurements they completed at baseline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
Completed

Started Jul 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 2, 2009

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

May 7, 2018

Status Verified

May 1, 2018

Enrollment Period

1.9 years

First QC Date

February 27, 2009

Last Update Submit

May 1, 2018

Conditions

Keywords

prostate canceraerobic exerciseresistance training

Outcome Measures

Primary Outcomes (1)

  • Feasibility of recruiting 60 men with prostate CA on ADT to an ex intervention study w/ three arms. To determine if an ex prgm provides symptom mgt as compared to usual care,if resistance training provides symptom mgt not obtained from aerobic ex alone.

    8 weeks

Study Arms (3)

aerobic exercise

EXPERIMENTAL

Subjects who are randomly assigned to this arm will be assigned a walking program to participate in 3 times a week for eight weeks

Behavioral: walking exercise

resistence training

EXPERIMENTAL

Subjects who are randomly assigned to this arm will be assigned a weight training program to participate in 3 times a week for eight weeks

Behavioral: weight training

Usual Care

ACTIVE COMPARATOR

Subjects who are randomly assigned to this arm will not participate in any exercise program and will continue with usual care treatment

Behavioral: Usual Care

Interventions

Subjects will be given an exercise prescription for walking 3 times a week for eight weeks

aerobic exercise
weight trainingBEHAVIORAL

participants will be given a weight training prescription to do 3 times a week for eight weeks.

resistence training
Usual CareBEHAVIORAL

Subjects in this arm will continue with their usual care and not start any exercise program for eight weeks.

Usual Care

Eligibility Criteria

Age40 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men with metastatic prostate cancer receiving ADT and men who have failed primary therapy and are receiving ADT.
  • Men from the radiology practice who are receiving ADT as neoadjuvant therapy to primary radiotherapy (enrolled only following completion of primary radiotherapy).

You may not qualify if:

  • Men with the following counter-indications to exercise:
  • Lower limb, bone, muscle, or joint pathology of a severity which limits their ability to be physically active.
  • A history of significant cardiac disease using criteria established by the American College of Sports Medicine ( Criteria: pain, discomfort in the chest, neck, jaw, arms, or other areas that may be due to ischemia; shortness of breath at rest or with mild exertion; ankle edema; palpitations or tachycardia; known heart murmur; unusual fatigue or shortness of breath with usual activities' syncope)
  • Other medical contraindications which would compromise participation in a lifestyle physical activity program.
  • Those who are currently physically active

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of medicine

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Kathleen Y Wolin, ScD

    Washington University School of Medicine in Saint Louis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2009

First Posted

March 2, 2009

Study Start

July 1, 2008

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

May 7, 2018

Record last verified: 2018-05

Locations